Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC–MS-based metabonomics

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition

(2016) M-L Wong et al.   MOLECULAR PSYCHIATRY

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

(2016) P Zheng et al.   MOLECULAR PSYCHIATRY

Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography–Mass Spectrometry

(2015) Xinyu Liu et al.   JOURNAL OF PROTEOME RESEARCH

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

(2015) Gislaine Z. Réus et al.   JOURNAL OF PSYCHIATRIC RESEARCH

MetaboAnalyst 3.0—making metabolomics more meaningful

(2015) Jianguo Xia et al.   NUCLEIC ACIDS RESEARCH

Fatty acid metabolism and its longitudinal relationship with the hypothalamic–pituitary–adrenal axis in major depression: Associations with prospective antidepressant response

(2015) Roel J.T. Mocking et al.   PSYCHONEUROENDOCRINOLOGY

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity

(2014) J. Assies et al.   ACTA PSYCHIATRICA SCANDINAVICA

Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia

(2014) Itaru Miura et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Plasma Galanin is a Biomarker for Severity of Major Depressive Disorder

(2014) Yong-Jun Wang et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

Polyunsaturated fatty acids and their metabolites in brain function and disease

(2014) Richard P. Bazinet et al.   NATURE REVIEWS NEUROSCIENCE

The Potential Biomarker Panels for Identification of Major Depressive Disorder (MDD) Patients with and without Early Life Stress (ELS) by Metabonomic Analysis

(2014) Xinghua Ding et al.   PLoS One

Sex-Specific Urinary Biomarkers for Diagnosing Bipolar Disorder

(2014) Jian-jun Chen et al.   PLoS One

Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms

(2014) Matthew Owens et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combined Application of NMR- and GC-MS-Based Metabonomics Yields a Superior Urinary Biomarker Panel for Bipolar Disorder

(2014) Jian-jun Chen et al.   Scientific Reports

A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder

(2013) Peng Zheng et al.   JOURNAL OF PROTEOME RESEARCH

The Human Urine Metabolome

(2013) Souhaila Bouatra et al.   PLoS One

The Role of Oxidative Stress in Depressive Disorders

(2012) Tanja Maria Michel et al.   CURRENT PHARMACEUTICAL DESIGN

Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder

(2012) Peng Zheng et al.   MOLECULAR & CELLULAR PROTEOMICS

Schizophrenia shows a unique metabolomics signature in plasma

(2012) Y He et al.   Translational Psychiatry

Evaluation of a novel ELISA for serotonin: urinary serotonin as a potential biomarker for depression

(2011) Mikaela I. Nichkova et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Cross-national epidemiology of DSM-IV major depressive episode

(2011) Evelyn Bromet et al.   BMC Medicine

Urinary Metabolite Markers of Precocious Puberty

(2011) Ying Qi et al.   MOLECULAR & CELLULAR PROTEOMICS

Potential metabolite markers of schizophrenia

(2011) J Yang et al.   MOLECULAR PSYCHIATRY

Of depression and immunity: does sex matter?

(2010) Pothitos M. Pitychoutis et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Sex, trauma, stress hormones and depression

(2009) E Young et al.   MOLECULAR PSYCHIATRY

Systems biology: Metabonomics

(2008) Jeremy K. Nicholson et al.   NATURE